Article
Neurosciences
Kexing Wan, Min Jia, Hong Zhang, Yuye Lan, Suixi Wang, Kailing Zhang, Zixiao Wang, He Zhu, Xunan Zheng, Yi Luo, Lei Pei, Caihua Wu, Yongmin Liu, Man Li
Summary: Neuropathic pain affects 7-10% of the general population worldwide. Electroacupuncture effectively relieves neuropathic pain symptoms without side effects, but the underlying molecular mechanisms are unclear. In this study, a rat model of neuropathic pain was induced and RNA sequencing was used to identify dysregulated genes. It was found that electroacupuncture inhibited ferroptosis and alleviated pain through the SAT1/ALOX15 pathway. These findings provide insights into the mechanisms of electroacupuncture and offer a new therapeutic target for neuropathic pain.
MOLECULAR NEUROBIOLOGY
(2023)
Article
Neurosciences
Jianxiong Wei, Shuyang Chang, Siyi Liu, Lixia Tian, Xuan Zhu, Shuo Wang, Xiaoqiong Zhou, Yuying Wang, Linping Xu, Fu-Quan Huo, Lingli Liang
Summary: In this study, researchers investigated the role of LSD1, a histone demethylase and transcriptional co-repressor, in radicular pain. They found that LSD1 was upregulated in compressed and injured nerve ganglia, suggesting it may contribute to pain hypersensitivities. These findings suggest that LSD1 could serve as a potential target for the treatment of radicular pain and neuropathic pain.
BRAIN RESEARCH BULLETIN
(2022)
Article
Immunology
Wen Chen, Xiaotong Wang, Qingyu Sun, Yurui Zhang, Jing Liu, Tingting Hu, Weihua Wu, Chao Wei, Meng Liu, Yumeng Ding, Dianxin Liu, Yingzi Chong, Peipei Wang, Hongwei Zhu, Weihua Cui, Jiannan Zhang, Qian Li, Fei Yang
Summary: The NLRP3 pathway is activated in the DRG of the DNP model, and TET2 is involved in DNP hypersensitivity by upregulating the TXNIP/NLRP3 pathway.
JOURNAL OF NEUROINFLAMMATION
(2022)
Article
Pharmacology & Pharmacy
Lina Huang, Dilip Sharma, Xiaozhou Feng, Zhiqiang Pan, Shaogen Wu, Daisy Munoz, Alex Bekker, Huijuan Hu, Yuan-Xiang Tao
Summary: The study found that RALY, an RNA-binding protein, plays a role in nerve trauma-induced nociceptive hypersensitivity by regulating the expression of translation initiation factor Eif4g2 in dorsal root ganglion neurons. Interventions targeting RALY expression levels could alleviate the development and maintenance of pain hypersensitivity.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Article
Immunology
Juping Xing, Hongji Wang, Lisha Chen, Hanxi Wang, Huan Huang, Jiabao Huang, Changshui Xu
Summary: This study investigated the role of Cx43 in neuropathic pain mediated by the P2X4 receptor in rats with chronic constriction injury (CCI). The results showed that blocking Cx43 can alleviate neuropathic pain in CCI rats through the P2X4, p38, ERK, and NF-kB signaling pathways. These findings suggest that Cx43 may be a promising therapeutic target for the development of novel pharmacological agents in the management of neuropathic pain.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Clinical Neurology
Li-Ping Xia, Hao Luo, Qiang Ma, Ya-Kai Xie, Wei Li, Hailan Hu, Zhen-Zhong Xu
Summary: GPR151 in nociceptive dorsal root ganglion neurons plays a crucial role in the pathogenesis of neuropathic pain by controlling neuronal hyperexcitability and promoting spinal microglial activation, indicating its potential as a therapeutic target for neuropathic pain treatment.
Article
Biochemistry & Molecular Biology
Jingjing Zhang, Lina Rong, Jinping Shao, Yidan Zhang, Yaping Liu, Sen Zhao, Lei Li, Wenli Yu, Mengya Zhang, Xiuhua Ren, Qingzan Zhao, Changlian Zhu, Huan Luo, Weidong Zang, Jing Cao
Summary: The study demonstrates that miR-137-mediated Kv1.2 impairment plays a crucial role in the pathogenesis of nerve injury-induced neuropathic pain, suggesting it as a novel potential therapeutic target for neuropathic pain management.
JOURNAL OF NEUROCHEMISTRY
(2021)
Article
Neurosciences
Bi-Xin Zheng, Ayma Malik, Ming Xiong, Alex Bekker, Yuan-Xiang Tao
Summary: Neuropathic pain is a common clinical disorder that significantly impacts patient quality of life and imposes a substantial economic and social burden. Opioids are currently the last resort for treatment, but their effectiveness is limited due to downregulation of opioid receptors in primary afferent neurons after peripheral nerve trauma. Recent studies have shown that epigenetic modifications, transcription factor expression changes, and alterations in post-translational processing may contribute to this downregulation of opioid receptors in nerve trauma-related dorsal root ganglion neurons. Understanding these molecular mechanisms could offer new approaches for preventing or treating neuropathic pain.
EXPERIMENTAL NEUROLOGY
(2021)
Article
Clinical Neurology
G. S. Piedade, S. Gillner, P. S. McPhillips, J. Vesper, P. J. Slotty
Summary: This study aimed to investigate the influence of stimulation frequency on pain reduction and quality of life in dorsal root ganglion stimulation (DRG-S). The results showed that lower stimulation frequencies were most effective in reducing neuropathic pain, significantly decreasing pain intensity and improving quality of life. Therefore, specific frequencies should be preferred based on the condition treated.
ACTA NEUROCHIRURGICA
(2022)
Article
Biochemistry & Molecular Biology
Ming-Chun Hsieh, Cheng-Yuan Lai, Li-Ting Lin, Dylan Chou, Chou-Ming Yeh, Jen-Kun Cheng, Hsueh-Hsiao Wang, Kuan-Hung Lin, Tzer-Bin Lin, Hsien-Yu Peng
Summary: The neurohormone melatonin shows promising potential in alleviating neuropathic pain caused by chemotherapy, with its analgesic effects mediated through melatonin receptor 2. Multiple administrations of melatonin during chemotherapy may be more effective in relieving allodynia/hyperalgesia and inhibiting the epigenetic program in neurons compared to a single administration after chemotherapy.
ACS CHEMICAL NEUROSCIENCE
(2023)
Article
Neurosciences
Donghang Zhang, Wenling Zhao, Jin Liu, Mengchan Ou, Peng Liang, Jia Li, Yali Chen, Daqing Liao, Siqi Bai, Jiefei Shen, Xiangdong Chen, Han Huang, Cheng Zhou
Summary: NALCN plays a significant role in chronic neuropathic pain, and knockdown of NALCN can significantly alleviate pain-related symptoms.
PROGRESS IN NEUROBIOLOGY
(2021)
Article
Anesthesiology
Zhen Zhang, Bixin Zheng, Shibin Du, Guang Han, Hui Zhao, Shaogen Wu, Shushan Jia, Thomas Bachmann, Alex Bekker, Yuan-Xiang Tao
Summary: The study revealed that eIF4G2 is involved in the genesis of neuropathic pain caused by nerve injury, by regulating the expression of MOR and Kv1.2 in the injured DRG, suggesting it as a potential target for treatment of this disorder.
BRITISH JOURNAL OF ANAESTHESIA
(2021)
Article
Biochemistry & Molecular Biology
Yueying Wang, Chenxi Li, Jingming Xing, Yan Zhu, Minghao Sun, Sui Yin, Jianming Liu, Lifang Zou, Shangdong Liang, Shuangmei Liu
Summary: This study found that neohesperidin can alleviate neuropathic pain by reducing P2X4R expression and inhibiting satellite glial cells activation.
NEUROCHEMICAL RESEARCH
(2023)
Article
Neurosciences
Siyi Liu, Shuting Yang, Xiaoqiong Zhou, Xuan Zhu, Linping Xu, Xiang Li, Zihao Gao, Tingkai Sun, Jianxiong Wei, Lixia Tian, Hong Cheng, Guihua Wei, Fu-Quan Huo, Lingli Liang
Summary: This study investigates the role of ApoE in the pathological development of neuropathic pain. The researchers found that ApoE is expressed in DRG satellite glial cells, macrophages, and spinal cord astrocytes. Nerve injury increased ApoE expression in injured DRGs and led to pain hypersensitivity, but not in the spinal cord. Targeting ApoE expression reduced pain hypersensitivity, and the receptor AXL may mediate ApoE function in neurons under neuropathic pain conditions.
Article
Anesthesiology
Michael Kretzschmar, Marco Reining
Summary: Stimulation of the dorsal root ganglion (DRG) has shown promise in providing relief for central poststroke pain, offering a potential non-drug therapy option for this often refractory chronic pain syndrome. This clinical observation builds on existing understanding of the pathophysiology of central pain and suggests a new avenue for managing the condition.